How does IDNA's PB Ratio compare to its peers?

Insufficient data to calculate IDNA's Price-To-Book Ratio vs. peers for valuation analysis.

How does IDNA's PB Ratio compare vs other companies in the Asian Healthcare Industry?

Insufficient data to calculate IDNA's Price-To-Book Ratio vs. industry for valuation analysis.

What is IDNA's PB Ratio compared to its Fair PB Ratio? This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

Insufficient data to calculate IDNA's Price-To-Book Fair Ratio for valuation analysis.

What is the Fair Price of IDNA when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Insufficient data to calculate IDNA's fair value for valuation analysis.

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Insufficient data to show price forecast.

IDNA Genomics CSE:IDNA Stock Report

Last Price

€27.00

Market Cap

€74.5m

7D

-0.7%

1Y

-0.7%

Updated

22 Dec, 2024

Data

Company Financials

IDNA Genomics Public Ltd

CSE:IDNA Stock Report

Market Cap: €74.5m

IDNA Stock Overview

Engages in the field of genomics and biotechnology and specializes in personalized health care. More details

IDNA fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Risk Analysis

Shares are highly illiquid

Has not reported any financial data

Does not have a meaningful market cap (€75M)

My Notes

Capture your thoughts, links and company narrative

IDNA Genomics Public Ltd Competitors

23andMe Holding

NasdaqCM:ME

US$84.5m

GUPPY's

TSE:5127

JP¥12.5b

Meribank Biotech

TPEX:4724

NT$2.5b

VITA 34

XTRA:V3V

€71.8m

Price History & Performance

Summary of share price highs, lows and changes for IDNA Genomics
Historical stock prices
Current Share Price	€27.00
52 Week High	€28.00
52 Week Low	€24.00
Beta	0
1 Month Change	-0.74%
3 Month Change	n/a
1 Year Change	-0.74%
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	12.50%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	IDNA	CY Healthcare	CY Market
7D	-0.7%	-2.1%	2.3%
1Y	-0.7%	-2.1%	50.6%

Return vs Industry: IDNA exceeded the CY Healthcare industry which returned -2.1% over the past year.

Return vs Market: IDNA underperformed the CY Market which returned 50.6% over the past year.

Price Volatility

Is IDNA's price volatile compared to industry and market?
IDNA volatility
IDNA Average Weekly Movement	n/a
Healthcare Industry Average Movement	5.3%
Market Average Movement	4.6%
10% most volatile stocks in CY Market	10.5%
10% least volatile stocks in CY Market	2.6%

Stable Share Price: IDNA's share price has been volatile over the past 3 months compared to the CY market.

Volatility Over Time: Insufficient data to determine IDNA's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2020	n/a	n/a	www.idnagenomicsplc.com

IDNA Genomics Public Ltd engages in the field of genomics and biotechnology and specializes in personalized health care. The company develops and provides genetic tests in the field of genomics. It also develops and markets pharmaceutical products.

IDNA Genomics Public Ltd Fundamentals Summary

How do IDNA Genomics's earnings and revenue compare to its market cap?
IDNA fundamental statistics
Market cap	€74.53m
Earnings (TTM)	€0
Revenue (TTM)	n/a

n/a

P/E Ratio

n/a

P/S Ratio

Is IDNA overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
IDNA income statement (TTM)
Revenue	€0
Cost of Revenue	€0
Gross Profit	€0
Other Expenses	€0
Earnings	€0

Last Reported Earnings

n/a

Next Earnings Date

n/a

Earnings per share (EPS)	0
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0.0%

How did IDNA perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/22 07:46
End of Day Share Price	2024/12/16 00:00
Earnings	N/A
Annual Earnings	N/A

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

IDNA Genomics Public Ltd is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution